Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 502.73M | 393.41M | 324.24M | 252.48M | 203M | 187.51M |
Cost of Revenue | 426.29M | 339.42M | 264.67M | 200.39M | 162.16M | 150.64M |
Gross Profit | 76.44M | 54M | 59.57M | 52.09M | 40.85M | 36.88M |
Operating Income | -36.08M | -60.12M | -77.02M | -81.95M | -45.86M | -8.2M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -60.74M | -64.66M | -83.1M | -91K | -11.6M | -14.81M |
Net Income | -60.61M | -64.66M | -83.07M | 152K | -10.93M | -14.32M |
Selling & General & Admin | 105.57M | n/a | n/a | n/a | n/a | 41.9M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 6.94M | 114.12M | 136.59M | 134.04M | 86.71M | 3.18M |
Operating Expenses | 112.52M | 114.12M | 136.59M | 134.04M | 86.71M | 45.07M |
Interest Expense | 11.28M | 7.5M | 6.78M | 4.08M | 320K | 347K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 41.59M |
Cost & Expenses | 538.81M | 453.53M | 401.26M | 334.43M | 248.86M | 195.71M |
Income Tax Expense | -131K | n/a | -36K | -243K | -671K | -492.82K |
Shares Outstanding (Basic) | 923.89M | 75.04M | 73.75M | 72.79M | 66.23M | 59.12M |
Shares Outstanding (Diluted) | 923.89M | 75.04M | 73.75M | 80.61M | 66.23M | 59.12M |
EPS (Basic) | -0.54 | -0.71 | -0.92 | 0 | -0.16 | -0.24 |
EPS (Diluted) | -0.54 | -0.71 | -0.92 | -0.21 | -0.16 | -0.24 |
EBITDA | -42.52M | -50.88M | -54.28M | -67.6M | -42.04M | -11.29M |
EBIT | -49.46M | -57.17M | -60.15M | -72.01M | -45.38M | -14.47M |
Depreciation & Amortization | 6.94M | 6.29M | 5.87M | 4.41M | 3.34M | 3.18M |
Add to Watchlist
Select watchlists to add or remove TOI